Fulgent Genetics (FLGT)

• Market cap: $534M
• 1 day: 2.43%
• 5 days: 1.23%
• 1 month: 13.29%
• 3 months: -6.03%
• 6 months: -17.85%
• Year to date: -6.03%
• 1 year: -20.67%
• 5 years: 77.72%
• 10 years: 88.56%
• Sector: Healthcare
• Industry: Medical Laboratories

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

4,613% more call options, than puts

Call options by funds: $43.5M | Put options by funds: $924K

40% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 50

24% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 25

3% more funds holding

Funds holding: 182 [Q3] → 187 (+5) [Q4]

1.39% more ownership

Funds ownership: 54.22% [Q3] → 55.62% (+1.39%) [Q4]

12% less capital invested

Capital invested by funds: $357M [Q3] → $314M (-$42.8M) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $16 8% downside
• Avg. target: $16 8% downside
• High target: $16 8% downside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Piper Sandler David Westenberg 44% 1-year accuracy 19 / 43 met price target

8% downside $16

Neutral Maintained

4 Mar 2025